Antineoplastic agents 220 synthesis of natural levo dolastatin 15
Pettit, G.R.; Herald, D.L.; Singh, S.B.; Thornton, T.J.; Mullaney, J.T.
Journal of the American Chemical Society 113(17): 6692-6693
1991
ISSN/ISBN: 0002-7863 Accession: 030125322
PDF emailed within 1 workday: $29.90
Related References
Pettit, G.R.; Smith, T.H.; Arce, P.M.; Flahive, E.J.; Anderson, C.R.; Chapuis, J.-C.; Xu, J.-P.; Groy, T.L.; Belcher, P.E.; Macdonald, C.B. 2015: Antineoplastic agents. 599. Total synthesis of dolastatin 16 Journal of Natural Products 78(3): 476-485Pettit, G.R.; Sing, S.B.; Hogan, F.; Lloyd Williams, P.; Herald, D.L.; Burkett, D.D.; Clewlow, P.J. 1989: The absolute configuration and synthesis of natural levo dolastatin 10 Journal of the American Chemical Society 111(14): 5463-5465
Pettit, G.R.; Nelson, P.S.; Holzapfel, C.W. 1985: Antineoplastic agents. 109. Structural biochemistry. 24. Synthesis of the cyclo-[(gly)Thz-(R)- and (S)-(gln)Thz-L-Val-L-Leu-L-Pro] isomers of dolastatin 3 The Journal of Organic Chemistry 50(15): 2654-2659
Pettit, G.R.; Holzapfel, C.W. 1986: Structural biochemistry. 25. Antineoplastic agents. 110. Synthesis of the dolastatin 3 isomer cyclo[L-Pro-L-Leu-L-Val-(R,S)-(gln)Thz-(gly)Thz] The Journal of Organic Chemistry 51(24): 4580-4585
Pettit, G.R.; Holzapfel, C.W. 1986: Structural biochemistry. 26. Antineoplastic agents. 111. Synthesis of the modified dolastatin 3 sequence cyclo-[L-Val-L-Leu-L-Pro-(R,S)-(gln)Thz-(gly)Thz] The Journal of Organic Chemistry 51(24): 4586-4590
Holzapfel, C.W.; Pettit, G.R. 1985: Antineoplastic agents. Par 108. Structural biochemistry. Part 23. Synthesis of the dolastatin thiazole amino acid component (gln)Thz The Journal of Organic Chemistry 50(13): 2323-2327
Pettit, G.R.; Flahive, E.J.; Boyd, M.R.; Bai, R.; Hamel, E.; Pettit, R.K.; Schmidt, J.M. 1998: Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications Anti-Cancer Drug Design 13(1): 47-66
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Pettit, G., R.; Xu, J.-Ping; Williams, M., D.; Hogan, F.; Schmidt, J., M.; Cerny, R., L. 1997: Antineoplastic agents 370: Isolation and structure of dolastatin 18 Bioorganic and Medicinal Chemistry Letters 7(7): 827-832
Pettit, G.R.; Kamano, Y.; Herald, C.L.; Dufresne, C.; Bates, R.B.; Schmidt, J.M.; Cerny, R.L.; Kizu, H. 1990: Antineoplastic agents 190 isolation and structure of the cyclodepsipeptide dolastatin 14 Journal of Organic Chemistry 55(10): 2989-2990
Poncet, J.; Busquet, M.; Roux, F.; Pierré, A.; Atassi, G.; Jouin, P. 1998: Synthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15 Journal of Medicinal Chemistry 41(9): 1524-1530
Pettit, G.R.; Flahive, E.J. 2004: Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same Official Gazette of the United States Patent and Trademark Office Patents 1279(1)
Rehnberg, N.; Magnusson, G. 1990: General conjugate addition method for the synthesis of enantiomerically pure lignans total synthesis of levo and dextro burseran levo dehydroxycubebin levo trichostin levo cubebin levo 5 ethoxyhinokinin and levo hinokinin Journal of Organic Chemistry 55(14): 4340-4349
Alcaro, S.; Marino, T.; Ortuso, F.; Russo, N. 2006: Conformational behavior of antineoplastic peptides Dolastatin 10 and Dolastatin 15 from Monte Carlo and molecular dynamics simulations International Journal of Quantum Chemistry 107(2): 318-325
Pettit, G.R.; Kamano, Y.; Brown, P.; Gust, D.; Inoue, M.; Herald, C.L. 1982: Antineoplastic agents. 3. Structure of the cyclic peptide dolastatin 3 from Dolabella auricularia Journal of the American Chemical Society 104(3): 905-907
Pettit, G.R.; Smith, T.H.; Xu, J.-P.; Herald, D.L.; Flahive, E.J.; Anderson, C.R.; Belcher, P.E.; Knight, J.C. 2011: Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units Journal of Natural Products 74(5): 1003-1008
Pettit, G.R.; Xu, J.-P.; Doubek, D.L.; Chapuis, J.-C.; Schmidt, J.M. 2004: Antineoplastic Agents. 510. Isolation and structure of dolastatin 19 from the Gulf of California sea hare Dolabella auricularia Journal of Natural Products 67(8): 1252-1255
Pettit, G.R.; Hogan, F.; Toms, S. 2011: Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10 Journal of Natural Products 74(5): 962-968
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Durkin, K.P.; Boyd, M.R.; Bai, R.; Hamel, E.; Schmidt, J.M.; Chapuis, J.C. 1995: Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications Anti-Cancer Drug Design 10(7): 529-544
Pettit, G.R.; Barkoczy, J. 2000: Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10 Official Gazette of the United States Patent and Trademark Office Patents 1232(1)